Abbvie CDR (Cad Hedged) (ABBV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 16,618,000 | 15,776,000 | 15,423,000 | 13,343,000 | 15,102,000 |
| Cost of Goods | 4,552,000 | 5,304,000 | 4,346,000 | 4,002,000 | 4,396,000 |
| Gross Profit | 12,066,000 | 10,472,000 | 11,077,000 | 9,341,000 | 10,706,000 |
| Operating Expenses | 6,257,000 | 5,888,000 | 5,360,000 | 5,360,000 | 10,622,000 |
| Operating Income | 5,809,000 | 4,584,000 | 5,717,000 | 3,981,000 | 84,000 |
| Interest Expense | 714,000 | 739,000 | 740,000 | 700,000 | 702,000 |
| Other Income | -2,427,000 | -3,131,000 | -3,423,000 | -1,620,000 | -1,651,000 |
| Pre-tax Income | 2,668,000 | 714,000 | 1,554,000 | 1,661,000 | -2,269,000 |
| Income Tax | 853,000 | 526,000 | 613,000 | 372,000 | -2,246,000 |
| Net Income Continuous | 1,815,000 | 188,000 | 941,000 | 1,289,000 | -23,000 |
| Minority Interests | 1,000 | -2,000 | -3,000 | -3,000 | 1,000 |
| Net Income | $1,816,000 | $186,000 | $938,000 | $1,286,000 | $-22,000 |
| EPS Basic Total Ops | 0.11 | 0.01 | 0.06 | 0.08 | 0.00 |
| EPS Basic Continuous Ops | 0.11 | 0.01 | 0.06 | 0.08 | 0.00 |
| EPS Diluted Total Ops | 0.11 | 0.01 | 0.06 | 0.08 | 0.00 |
| EPS Diluted Continuous Ops | 0.11 | 0.01 | 0.06 | 0.08 | 0.00 |
| EBITDA(a) | $5,369,000 | $3,516,000 | $4,344,000 | $4,400,000 | $535,000 |